CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 12 enrolled
Drug / intervention
Ketaminedrug
Likely dose
Ketamine 0.25mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01369680
NCT01369680Phase 1Completed
CompareCT.gov

Oral Ketamine for Control of Chronic Pain in Children

University of Rochester·interventional·Posted Jun 9, 2011·Updated Feb 15, 2013

In Brief

A Phase 1 clinical trial evaluating Ketamine for Chronic Pain. Completed, enrolled 12 participants across 1 site.

Detailed Summary

The study is a maximum tolerated dose finding study for oral, chronic, daily administration of oral ketamine (by mouth) in children with long-term daily pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pain
CountriesUnited States
Collaborators--

Timeline

Phase 1CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJun 9, 2011
Enrollment StartMay 1, 2011
Primary CompletionOct 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 15.1 years ago

Interventions

Ketaminedrug

Drug will be given orally three times a day at doses escalating from 0.25mg/kg/dose to 1.5mg/kg/dose in cohorts of 3. Each subject will be administered study drug for 2 weeks.